Safety concerns over active surveillance for intermediate-risk prostate cancer
/Dr David Samadi provides his expert opinion on a recent study regarding whether active surveillance for men with intermediate-risk prostate cancer can be safely used as a means of overseeing the disease without over treating it.
Read More